% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Galldiks:826480,
author = {Galldiks, Norbert and Law, Ian and Pope, Whitney B. and
Arbizu, Javier and Langen, Karl-Josef},
title = {{T}he use of amino acid {PET} and conventional {MRI} for
monitoring of brain tumor therapy},
journal = {NeuroImage: Clinical},
volume = {13},
issn = {2213-1582},
address = {[Amsterdam u.a.]},
publisher = {Elsevier},
reportid = {FZJ-2017-00705},
pages = {386 - 394},
year = {2017},
abstract = {Routine diagnostics and treatment monitoring of brain
tumors is usually based on contrast-enhanced MRI. However,
the capacity of conventional MRI to differentiate tumor
tissue from posttherapeutic effects following neurosurgical
resection, chemoradiation, alkylating chemotherapy,
radiosurgery, and/or immunotherapy may be limited. Metabolic
imaging using PET can provide relevant additional
information on tumor metabolism, which allows for more
accurate diagnostics especially in clinically equivocal
situations. This review article focuses predominantly on the
amino acid PET tracers 11C-methyl-l-methionine (MET),
O-(2-[18F]fluoroethyl)-l-tyrosine (FET) and
3,4-dihydroxy-6-[18F]-fluoro-l-phenylalanine (FDOPA) and
summarizes investigations regarding monitoring of brain
tumor therapy.},
cin = {INM-3 / INM-4},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406 / I:(DE-Juel1)INM-4-20090406},
pnm = {572 - (Dys-)function and Plasticity (POF3-572)},
pid = {G:(DE-HGF)POF3-572},
typ = {PUB:(DE-HGF)16},
UT = {WOS:000401413700045},
pubmed = {pmid:28116231},
doi = {10.1016/j.nicl.2016.12.020},
url = {https://juser.fz-juelich.de/record/826480},
}